Essentia Health Menu
Home > Education & Research > Research to Improve Health Care > Participating in Research > Clinical Trials > Clinical Trials Details
<< Back to Results
Surveillance of primary prevention with aspirin is part of the Minnesota Heart Health Program – Partners in Prevention (MHHP-PiP), a key program of the University of Minnesota and the Minnesota Department of Health with promotes recommended use of low-dose aspirin to prevent heart attack and stroke in targeted age groups of patients. MHHP-PiP includes public awareness messaging and health system quality improvement initiative that encompasses provider education, best practice alerts and health outcome surveillance. Contact Irina Haller at 218-786-8185 for further information.
For more information about a financial conflict of interest (FCOI), review the Essentia Health FCOI policy.
Last Updated: 12/29/2015